Published on: July 31, 2019 at 09:30PM
Condition: Type 2 Diabetes
Interventions: Drug: Tirzepatide; Drug: Placebo
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/32YnV8F
Wednesday, 31 July 2019
New diabetes clinical trial: A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.